1. Home
  2. AUPH vs BHLB Comparison

AUPH vs BHLB Comparison

Compare AUPH & BHLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUPH
  • BHLB
  • Stock Information
  • Founded
  • AUPH 1993
  • BHLB 1846
  • Country
  • AUPH Canada
  • BHLB United States
  • Employees
  • AUPH N/A
  • BHLB N/A
  • Industry
  • AUPH Biotechnology: Pharmaceutical Preparations
  • BHLB Banks
  • Sector
  • AUPH Health Care
  • BHLB Finance
  • Exchange
  • AUPH Nasdaq
  • BHLB Nasdaq
  • Market Cap
  • AUPH 1.1B
  • BHLB 1.2B
  • IPO Year
  • AUPH 1999
  • BHLB 2000
  • Fundamental
  • Price
  • AUPH $8.77
  • BHLB $25.18
  • Analyst Decision
  • AUPH Strong Buy
  • BHLB Hold
  • Analyst Count
  • AUPH 2
  • BHLB 5
  • Target Price
  • AUPH $11.50
  • BHLB $32.70
  • AVG Volume (30 Days)
  • AUPH 1.4M
  • BHLB 484.0K
  • Earning Date
  • AUPH 07-31-2025
  • BHLB 07-17-2025
  • Dividend Yield
  • AUPH N/A
  • BHLB 2.86%
  • EPS Growth
  • AUPH N/A
  • BHLB 392.17
  • EPS
  • AUPH 0.27
  • BHLB 2.46
  • Revenue
  • AUPH $247,295,000.00
  • BHLB $431,403,000.00
  • Revenue This Year
  • AUPH $12.15
  • BHLB $31.27
  • Revenue Next Year
  • AUPH $18.31
  • BHLB $78.77
  • P/E Ratio
  • AUPH $31.76
  • BHLB $10.21
  • Revenue Growth
  • AUPH 29.20
  • BHLB 33.05
  • 52 Week Low
  • AUPH $5.20
  • BHLB $22.03
  • 52 Week High
  • AUPH $10.67
  • BHLB $32.36
  • Technical
  • Relative Strength Index (RSI)
  • AUPH 66.00
  • BHLB 53.76
  • Support Level
  • AUPH $7.71
  • BHLB $24.46
  • Resistance Level
  • AUPH $8.29
  • BHLB $25.25
  • Average True Range (ATR)
  • AUPH 0.25
  • BHLB 0.50
  • MACD
  • AUPH 0.03
  • BHLB 0.05
  • Stochastic Oscillator
  • AUPH 84.40
  • BHLB 76.31

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

About BHLB Berkshire Hills Bancorp Inc.

Berkshire Hills Bancorp Inc is a holding company. It provides Commercial Banking, Retail Banking, Consumer Lending, Private Banking and Wealth Management services.

Share on Social Networks: